What To Watch For Amid Biotech’s Resurgence
It’s been a slog for biotech stocks in 2024. But that shouldn’t necessarily be the case, as artificial intelligence (AI) has created limitless potential in…
It’s been a slog for biotech stocks in 2024. But that shouldn’t necessarily be the case, as artificial intelligence (AI) has created limitless potential in…
The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2025, according to Statista. A large portion of that figure is from…
Health care stocks lagged the S&P 500 in 2023, but they can often be a solid defensive play in an uncertain economy. People don’t typically…
Thanks to ample customer demand, production increases, and an improving global supply chain for drug transport and delivery, the worldwide diabetes and weight loss drug…
Morningstar.com published an interesting piece in July about the long-term health care crisis. It pointed out that Americans paid out $245 billion for long term…
When the human genome was fully sequenced in 2003, the prospects of genetic medicine ushered in a new era of human health. Today, scientists and…
The healthcare sector continues to be a hotbed of innovation, with biotechnology leading the charge. From groundbreaking gene therapies to next-generation cancer treatments, biotech companies…
The healthcare sector is often considered a defensive play, with healthcare stocks to buy offering stability and growth potential even during economic downturns. The sector’s…
Finding firms with strong growth potential is essential for healthcare investors looking for large profits. Three exceptional firms have surfaced as strong healthcare stocks. Each…
The future of the U.S. economy appears promising, with robust growth and strong corporate performance. This economic strength has propelled the stock market to record…